MedTrace Logo

Circulating Tumor Cell Detection in Hepatocellular Carcinoma

NCT05297955 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 458

Last updated 2022-04-06

No results posted yet for this study

Summary

The investigators examined circulating tumor cells (CTC) in the perioperative peripheral blood of hundreds of HCC patients undergoing liver cancer surgery using CellSearch technology between 2013 and 2016. Although the investigators have done a preliminary study of the above data and published some results, the previous study was only a basic analysis. Now the investigators plan to carry out further in-depth analysis of these data, including hospitalization data, follow-up results, surgical tumors and blood specimens, and make full use of biostatistics, molecular biology, pathology and other related techniques to elucidate the association between the levels of CTC or CTC clusters and patients' disease during the perioperative period, and to explore the molecular basis of CTC production in hepatocellular carcinoma.

Conditions

  • Circulating Tumor Cell

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Xiaoping Chen · Tongji Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-01
Primary Completion
2016-06-30
Completion
2022-03-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05297955 on ClinicalTrials.gov